½ÃÀ庸°í¼­
»óǰÄÚµå
1618605

¼¼°èÀÇ ¸ÞµðÄà À̹Ì¡ ½ÃÀå : ¸ð´Þ¸®Æ¼, ÃÖÁ¾»ç¿ëÀÚ, ¿ëµµº° ¿¹Ãø(2025-2030³â)

Medical Imaging Market by Modality (Computed Tomography, Fluoroscopy, Mammography), End-User (Diagnostic Centers, Hospitals), Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 184 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¸ÞµðÄà À̹Ì¡ ½ÃÀåÀº 2023³â¿¡ 540¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 612¾ï 2,000¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 14.45%·Î ¼ºÀåÇϰí, 2030³â¿¡´Â 1,391¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ÞµðÄà À̹Ì¡ÀÇ ´ë»ó ¹üÀ§¿¡´Â X¼±, CT ½ºÄµ, MRI, ÃÊÀ½ÆÄ, PET ½ºÄµ µî Áø´Ü, ¸ð´ÏÅ͸µ, Ä¡·á ¸ñÀûÀ¸·Î ÀÎüÀÇ »ó¼¼ÇÑ ³»ºÎ À̹ÌÁö¸¦ ¾ò´Â µ¥ »ç¿ëµÇ´Â ´Ù¾çÇÑ ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. ¸ÞµðÄà À̹Ì¡ÀÇ Çʿ伺Àº ±â°£ Áø´ÜÀ» À§ÇÑ ºñħ½ÀÀû ¹æ¹ýÀ» Á¦°øÇϰí, Ä¡·á °áÁ¤À» À̲ø°í, ȯÀÚÀÇ °á°ú¸¦ Çâ»ó½ÃŰ´Â ´É·Â¿¡ ÀÖ½À´Ï´Ù. ½ÉÀåÇÐ, ³ú ¿µ»óÈ­¸¦ À§ÇÑ ½Å°æÇÐ, »À Æò°¡¸¦ À§ÇÑ ¼ºÇü ¿ÜºÎ °úÇÐ µîÀÌ ÀÖ½À´Ï´Ù. ÃÖÁ¾ ¿ëµµ´Â º´¿ø, Áø´Ü¼¾ÅÍ, ¿¬±¸ ±â°ü µîÀÔ´Ï´Ù. ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀº À̹ÌÁö Á¤¹Ðµµ¿Í ÆÇµ¶ ¼Óµµ¸¦ Çâ»ó½ÃŰ°í ±Ã±ØÀûÀ¸·Î ÀÓ»ó °á°ú¸¦ °³¼±ÇÔÀ¸·Î½á Å« ºñÁî´Ï½º ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 540¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 612¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 1,391¾ï ´Þ·¯
CAGR(%) 14.45%

±×·¯³ª ³ôÀº Àåºñ ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ¼÷·ÃµÈ ¹æ»ç¼± ±â»çÀÇ ºÎÁ· µî ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÏ´Â ÇѰè¿Í °úÁ¦µµ Á¸ÀçÇÕ´Ï´Ù. Àú¼±·® ¹æ»ç¼± ±â¼úÀÇ Çõ½ÅÀ̳ª ¿ø°ÝÁö¿ëÀÇ ÈÞ´ë¿ë È­»ó Áø´Ü ÀåÄ¡ÀÇ °³¹ßÀº ¿¬±¸ °³¹ßÀÇ À¯¸Á ºÐ¾ßÀÔ´Ï´Ù. ±âÁ¸ ±â¾÷ÀÇ Á¸Àç ¿¡ ÀÇÇØ Ư¡ Áö¾îÁý´Ï´Ù. ÇÏÀ̺긮µå À̹Ì¡ ½Ã½ºÅÛ°ú ¸ÖƼ ¸ð´Þ¸®Æ¼ À̹Ì¡À» ÇâÇÑ µ¿ÇâÀº ÇâÈÄ ¼ºÀåÀ» À̲ø °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. AI ÁÖµµÀÇ ºÐ¼®°ú Ŭ¶ó¿ìµå ±â¹ÝÀÇ À̹ÌÁö ¼Ö·ç¼Ç¿¡ ÅõÀÚÇÔÀ¸·Î½á ÀÌ ÁøÈ­ÇÏ´Â ½ÃÀå¿¡¼­ »õ·Î¿î ±âȸ¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¸ÞµðÄà À̹Ì¡ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¸ÞµðÄà À̹Ì¡ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ëÀ» ÅëÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ±×¸®°í »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇϽʽÿÀ. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °íÇØ»óµµ À̹Ì¡À̳ª 3D/4D À̹Ì¡ ±â¼ú µîÀÇ ±â¼ú Çõ½Å
    • ¸¸¼º Áúȯ Áõ°¡
    • Á¤ºÎÀÇ ÇコÄɾî ÁöÃâ ¹× ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¸ÞµðÄà À̹Ì¡ ±â±âÀÇ ±ÔÁ¦¿Í »óȯÀÇ ¹®Á¦
  • ½ÃÀå ±âȸ
    • ¸ÞµðÄà À̹Ì¡ µð¹ÙÀ̽º¿¡ AI ¹× ¸Ó½Å·¯´× ±â¼ú ÅëÇÕ
    • ÈÞ´ë¿ë µð¹ÙÀ̽º¿Í ¹«¼± µð¹ÙÀ̽ºÀÇ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß
  • ½ÃÀåÀÇ °úÁ¦
    • ¹æ»ç¼±ÇÇÆøÀÇ À§Ç輺¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Force : ¸ÞµðÄà À̹Ì¡ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force´Â ¸ÞµðÄà À̹Ì¡ ½ÃÀå °æÀï ±¸µµ¸¦ ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¸ÞµðÄà À̹Ì¡ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¸ÞµðÄà À̹Ì¡ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ÕÀ¸·Î ¿¹»óÇÑ Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¸ÞµðÄà À̹Ì¡ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

¸ÞµðÄà À̹Ì¡ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁß, ´ÜÆíÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ ÇØÁü¿¡ µû¶ó ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¸ÞµðÄà À̹Ì¡ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¸ÞµðÄà À̹Ì¡ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±âº» °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐÇÒÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : ¸ÞµðÄà À̹Ì¡ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

¸ÞµðÄà À̹Ì¡ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • °íÇØ»óµµ È­»óÀ̳ª 3D/4D È­»ó ±â¼ú µîÀÇ ±â¼ú Çõ½Å
      • ¸¸¼º Áúȯ Áõ°¡
      • Á¤ºÎÀÇ ÀÇ·áºñ ÁöÃâ°ú ÀÇ·á ÀÎÇÁ¶ó ÅõÀÚ Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ¸ÞµðÄà À̹Ì¡ µð¹ÙÀ̽ºÀÇ ±ÔÁ¦¿Í »óȯÀÇ ¹®Á¦
    • ±âȸ
      • ¸ÞµðÄà À̹Ì¡ µð¹ÙÀ̽º¿¡ AI¿Í ¸Ó½Å·¯´× ±â¼úÀÇ ÅëÇÕ
      • ÈÞ´ë¿ë ¹× ¹«¼± ÀåÄ¡ÀÇ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß
    • °úÁ¦
      • ¹æ»ç¼± ÇÇÆøÀÇ À§Ç輺¿¡ °üÇÑ ¿ì·Á
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • ¸ð´Þ¸®Æ¼: ½Å°æÇÐÀû Æò°¡¿¡ À־ÀÇ MRIÀÇ ÀÌ¿ë Áõ°¡
    • ¿ëµµ: º¹ÀâÇÑ ½ÉÀ庴ÀÇ Á¶±â ¹ß°ßÀ» À§ÇÑ ½ÉÀ庴Çп¡¼­ÀÇ ´Ù¾çÇÑ ÀÀ¿ë ¹üÀ§
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ¸ÞµðÄà À̹Ì¡ ½ÃÀå : ¸ð´Þ¸®Æ¼º°

  • ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ
    • ÇÏÀÌ¿£µå ½ºÄ³³Ê(128 ½½¶óÀ̽º ÀÌ»ó)
    • ·Î¿ì¿£µå ½ºÄ³³Ê(-16 ½½¶óÀ̽º)
    • ¹Ìµå·¹ÀÎÁö ½ºÄ³³Ê(¾à 64 ½½¶óÀ̽º)
  • Åõ½Ã °Ë»ç
  • À¯¹æ Á¶¿µ
  • MRI
    • °íÀÚÀå MRI ½Ã½ºÅÛ(1.5-3T)
    • ÀúÀÚÀå ¹× ÁßÀÚÀå MRI ½Ã½ºÅÛ(1.5 T ¹Ì¸¸)
    • ÃʰíÀÚÀå ¹× ÃʰíÀÚÀå MRI ½Ã½ºÅÛ(3T ÀÌ»ó)
  • ÇÙ¿µ»ó
  • ÃÊÀ½ÆÄ
    • 2D ÃÊÀ½ÆÄ
    • 3D ÃÊÀ½ÆÄ
  • X¼±
    • ¾Æ³¯·Î±× ½Ã½ºÅÛ
    • µðÁöÅÐ ½Ã½ºÅÛ

Á¦7Àå ¸ÞµðÄà À̹Ì¡ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Áø´Ü¼¾ÅÍ
  • º´¿ø

Á¦8Àå ¸ÞµðÄà À̹Ì¡ ½ÃÀå : ¿ëµµº°

  • ½ÉÀ庴ÇÐ
  • ¼ÒÈ­±â ³»°ú
  • ºÎÀΰú
  • ½Å°æÇÐ
  • Á¾¾çÇÐ
  • Á¤Çü¿Ü°ú

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ¸ÞµðÄà À̹Ì¡ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¸ÞµðÄà À̹Ì¡ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¸ÞµðÄà À̹Ì¡ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Clario¿Í Emsere°¡ ¾È°ú ÀÓ»ó½ÃÇè °­È­¸¦ À§ÇØ Àü·«Àû Á¦ÈÞ¸¦ ü°á
    • ÀÇ·á Çõ½ÅÀÇ °­È­, °íǰÁúÀÇ ¸ÞµðÄà À̹Ì¡ µ¥ÀÌÅÍ¿¡ÀÇ È¿À²ÀûÀÎ ¾×¼¼½º¸¦ À§ÇÑ °øµ¿ ÀÌ´Ï¼ÅÆ¼ºê
    • Philips°¡ ÃÖ÷´ÜÀÇ ¸ÞµðÄà À̹Ì¡ ¼Ö·ç¼ÇÀ» ¹ßÇ¥, Áø´ÜÀÇ ½Å·Ú¼º°ú ¿î¿ë È¿À²À» Çâ»ó
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • ADLINK Technology Inc.
  • Advantech Co., Ltd.
  • Ampronix, LLC
  • Aspect Imaging Ltd.
  • Canon Medical Systems Corporation
  • Carestream Health
  • Cubresa Inc.
  • EIZO Corporation
  • ESAOTE SPA
  • FUJIFILM VisualSonics Inc.
  • GE Healthcare
  • Hitachi Ltd.
  • Hologic, Inc.
  • Koning Corporation
  • Koninklijke Philips NV
  • Mindray Medical International Limited
  • MR Solutions Ltd.
  • Olympus Corporation
  • PerkinElmer Inc.
  • Samsung Healthcare
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Smith & Nephew PLC
  • TEAC Corporation
  • Ziehm Imaging Inc.
JHS 24.12.30

The Medical Imaging Market was valued at USD 54.05 billion in 2023, expected to reach USD 61.22 billion in 2024, and is projected to grow at a CAGR of 14.45%, to USD 139.10 billion by 2030.

The scope of medical imaging encompasses various technologies such as X-rays, CT scans, MRIs, ultrasounds, and PET scans, used to obtain detailed internal views of the human body for diagnosis, monitoring, and treatment purposes. The necessity of medical imaging lies in its ability to provide non-invasive methods for early diagnosis, guide treatment decisions, and enhance patient outcomes. Key applications include oncology for tumor detection and monitoring, cardiology to visualize heart anomalies, neurology for brain imaging, and orthopedics for bone assessment. End-use sectors span hospitals, diagnostic centers, and research institutions. Strong growth factors influencing the market include advancements in imaging technology, increasing incidence of chronic diseases, and rising demand for early diagnostics. The integration of artificial intelligence and machine learning into imaging systems presents significant opportunities by enhancing image accuracy and interpretation speed, ultimately improving clinical outcomes. Moreover, the growing demand from emerging markets due to improving healthcare infrastructure and increasing awareness offers lucrative prospects for expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 54.05 billion
Estimated Year [2024] USD 61.22 billion
Forecast Year [2030] USD 139.10 billion
CAGR (%) 14.45%

However, there are limitations and challenges, such as high equipment costs, stringent regulatory requirements, and a shortage of skilled radiologists that can hinder market growth. Additionally, concerns regarding patient exposure to radiation and data privacy present further challenges. Innovating in low-dose radiation technologies and developing portable imaging devices for remote settings are promising areas for research and development. The market is competitive, characterized by rapid technological development and the presence of established players investing in R&D to stay ahead. The industry trends towards hybrid imaging systems and multi-modality imaging are expected to drive future growth. Companies should focus on collaborations and partnerships for technology integration and training programs to address the skilled workforce gap. Investing in AI-driven analytics and cloud-based imaging solutions can capture emerging opportunities in this evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Imaging Market

The Medical Imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Technological innovations such as high-resolution imaging and 3D/4D imaging techniques
    • Increasing prevalence of chronic diseases
    • Increased government healthcare expenditure and investment in health infrastructure
  • Market Restraints
    • Regulatory and reimbursement issues of medical imaging devices
  • Market Opportunities
    • Integration of AI and machine learning technologies in medical imaging devices
    • Ongoing R&D into portable and wireless devices
  • Market Challenges
    • Concerns regarding the radiation exposure dangers

Porter's Five Forces: A Strategic Tool for Navigating the Medical Imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Imaging Market

A detailed market share analysis in the Medical Imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Imaging Market

A strategic analysis of the Medical Imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Imaging Market, highlighting leading vendors and their innovative profiles. These include ADLINK Technology Inc., Advantech Co., Ltd., Ampronix, LLC, Aspect Imaging Ltd., Canon Medical Systems Corporation, Carestream Health, Cubresa Inc., EIZO Corporation, ESAOTE SPA, FUJIFILM VisualSonics Inc., GE Healthcare, Hitachi Ltd., Hologic, Inc., Koning Corporation, Koninklijke Philips N.V., Mindray Medical International Limited, MR Solutions Ltd., Olympus Corporation, PerkinElmer Inc., Samsung Healthcare, Shimadzu Corporation, Siemens Healthineers AG, Smith & Nephew PLC, TEAC Corporation, and Ziehm Imaging Inc..

Market Segmentation & Coverage

This research report categorizes the Medical Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Modality, market is studied across Computed Tomography, Fluoroscopy, Mammography, MRI, Nuclear Imaging, Ultrasound, and X-Ray. The Computed Tomography is further studied across High End Scanners (128-Slice & More), Low End Scanners (~16-Slice), and Mid Range Scanners (~64-Slice). The MRI is further studied across High Field MRI systems (1.5-3 T), Low & Mid Field MRI Systems (Less Than 1.5 T), and Very High, & Ultra High Field MRI Systems (3T & More). The Ultrasound is further studied across 2D Ultrasound and 3D Ultrasound. The X-Ray is further studied across Analog Systems and Digital Systems.
  • Based on End-User, market is studied across Diagnostic Centers and Hospitals.
  • Based on Application, market is studied across Cardiology, Gastroenterology, Gynecology, Neurology, Oncology, and Orthopedics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Technological innovations such as high-resolution imaging and 3D/4D imaging techniques
      • 5.1.1.2. Increasing prevalence of chronic diseases
      • 5.1.1.3. Increased government healthcare expenditure and investment in health infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Regulatory and reimbursement issues of medical imaging devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of AI and machine learning technologies in medical imaging devices
      • 5.1.3.2. Ongoing R&D into portable and wireless devices
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding the radiation exposure dangers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Modality: Increasing utilization of MRI for neurological assessments
    • 5.2.2. Application: Diverse scope of applications in cardiology for early detection of complex cardiac conditions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Imaging Market, by Modality

  • 6.1. Introduction
  • 6.2. Computed Tomography
    • 6.2.1. High End Scanners (128-Slice & More)
    • 6.2.2. Low End Scanners (~16-Slice)
    • 6.2.3. Mid Range Scanners (~64-Slice)
  • 6.3. Fluoroscopy
  • 6.4. Mammography
  • 6.5. MRI
    • 6.5.1. High Field MRI systems (1.5-3 T)
    • 6.5.2. Low & Mid Field MRI Systems (Less Than 1.5 T)
    • 6.5.3. Very High, & Ultra High Field MRI Systems (3T & More)
  • 6.6. Nuclear Imaging
  • 6.7. Ultrasound
    • 6.7.1. 2D Ultrasound
    • 6.7.2. 3D Ultrasound
  • 6.8. X-Ray
    • 6.8.1. Analog Systems
    • 6.8.2. Digital Systems

7. Medical Imaging Market, by End-User

  • 7.1. Introduction
  • 7.2. Diagnostic Centers
  • 7.3. Hospitals

8. Medical Imaging Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Gastroenterology
  • 8.4. Gynecology
  • 8.5. Neurology
  • 8.6. Oncology
  • 8.7. Orthopedics

9. Americas Medical Imaging Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Medical Imaging Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Medical Imaging Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Clario and Emsere Form Strategic Alliance to Enhance Ophthalmic Clinical Trials
    • 12.3.2. Enhancing Medical Innovations, A Collaborative Initiative for Streamlined Access to High-Quality Medical Imaging Data
    • 12.3.3. Philips Unveils Cutting-Edge Medical Imaging Solutions, Enhancing Diagnostic Confidence and Operational Efficiency
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ADLINK Technology Inc.
  • 2. Advantech Co., Ltd.
  • 3. Ampronix, LLC
  • 4. Aspect Imaging Ltd.
  • 5. Canon Medical Systems Corporation
  • 6. Carestream Health
  • 7. Cubresa Inc.
  • 8. EIZO Corporation
  • 9. ESAOTE SPA
  • 10. FUJIFILM VisualSonics Inc.
  • 11. GE Healthcare
  • 12. Hitachi Ltd.
  • 13. Hologic, Inc.
  • 14. Koning Corporation
  • 15. Koninklijke Philips N.V.
  • 16. Mindray Medical International Limited
  • 17. MR Solutions Ltd.
  • 18. Olympus Corporation
  • 19. PerkinElmer Inc.
  • 20. Samsung Healthcare
  • 21. Shimadzu Corporation
  • 22. Siemens Healthineers AG
  • 23. Smith & Nephew PLC
  • 24. TEAC Corporation
  • 25. Ziehm Imaging Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦